1-2 of 2
K. C. Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Clinical Trial of KOS-953 + Bortezomib (BZ) in Relapsed Refractory Multiple Myeloma (MM).

Free
Asher Alban Chanan-Khan, MD, P. G. Richardson, MD, M. Alsina, MD, M. Carroll, MD, S. Lonial, MD, A. Krishnan, MD, M. Albitar, MD, Y. Zhou, MD, C. Mitsiades, MD, G. Cropp, MS, A. L. Hannah, MD, K. C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 362.
https://doi.org/10.1182/blood.V106.11.362.362
Published: 2005
Journal Articles

CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines

Free
G. Teoh, Y.-T. Tai, M. Urashima, S. Shirahama, M. Matsuzaki, D. Chauhan, S. P. Treon, N. Raje, T. Hideshima, Y. Shima, K. C. Anderson
Journal: Blood
Blood (2000) 95 (3): 1039–1046.
https://doi.org/10.1182/blood.V95.3.1039.003k02_1039_1046
Published: 2000